Differences Between Glycemia Estimates from Hemoglobin A1c and Continuous Glucose Monitoring and Their Association with Complete Blood Counts
CBC measurements are associated with differences between estimates of glycemia derived from HbA1c and CGM. Further studies with longer periods of CGM are needed to determine whether CBCs can complement HbA1c and CGM and can help reconcile differences in estimates of mean glycemia provided by HbA1c and CGM.
Authors
- John M. Lachin (ORCID: https://orcid.org/0000-0001-9838-2841)
- Nicole M. Butera (ORCID: https://orcid.org/0000-0002-8901-3881)
- J. Higgins
- Heidi Krause‐Steinrauf (ORCID: https://orcid.org/0000-0001-6894-4110)
- Veronica Tozzo (ORCID: https://orcid.org/0000-0001-8538-9198)
- David M. Nathan
Institutions
- Milken Institute (US)
- Harvard University (US)
- University of California, Los Angeles (US)
- George Washington University (US)
- Massachusetts General Hospital (US)
- Cincinnati VA Medical Center (US)
- Center for Systems Biology (US)
- Mass General Brigham (US)
- University of Cincinnati (US)
Publication Details
- Journal
- Diabetes Technology & Therapeutics
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1177/15209156251395036
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Diabetes Association
- U.S. Department of Veterans Affairs
- Abbott Laboratories
- Bristol-Myers Squibb
- Sanofi
- Asahi Kasei Pharma Corporation
- Dexcom
- BD
- Novo Nordisk
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Heart, Lung, and Blood Institute
- National Institute of Diabetes and Digestive and Kidney Diseases